Resources with keywords: children



The WHO AWaRe (Access, Watch, Reserve) antibiotic book
World Health Organization (WHO)

The WHO AWaRe (Access, Watch, Reserve) antibiotic book provides information on antibiotis, dose, route of administration, and duration of treatment for more than 30 of the most common clinical infections in children and adults.

keywords: AR/AMR, children
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023 (NEW 7/11, Website, Publication)
CDC/MMWR
16 June 2023

Moulia DL, Wallace M, Roper LE, et al.
Updated vaccine recommendations for children > 6 months and adults >65.

Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023 (NEW 7/11, Website, Publication)
CDC/MMWR
9 June 2023

Hause AM, Marquez P, Zhang B, et al.

Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection — United States (Website, Publication, Regulatory)
CDC/MMWR
16 December 2022

Melgar M, Lee EH, Miller AD, et al.

Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022 (NEW 7/14, Website, Regulatory)
CDC/MMWR
28 June 2022
COVID-19 Vaccination for Children and Teens with Disabilities (NEW 5/6, Website, Regulatory)
CDC
Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young Children (NEW 5/6, Website, Regulatory)
FDA
25 April 2022
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 (NEW 5/6, Website, Publication)
CDC/MMWR
22 April 2022

Shi DS, Whitaker M, Marks KJ, et al.

Outcomes of SARS-CoV-2–Positive Youths Tested in Emergency Departments: The Global PERN–COVID-19 Study (NEW 2/3, Website, Publication)
JAMA Network Open
11 January 2022

Funk AL, et al.

Among 3221 SARS-CoV-2–positive youths enrolled in a global prospective cohort study with outcome data, 3.3% had severe outcomes within 14 days. Across a subgroup of 2510 SARS-CoV-2–positive youths discharged home after testing, 0.5% had severe outcomes during the 2-week follow-up period.

About the COVID-19 Vaccine: Frequently Asked Questions (NEW 11/30, Website)
American Academy of Pediatrics (AAP)

The AAP maintains this section on COVID-19 and the pediatric population. It includes FAQs, vaccination recommendations, vaccine research, post vaccination monitoring and more.

Go to Top